Alembic Pharma plans Rs 720-crore capex for FY19 Industry-The Economic Times — June 3, 2018 comments off The pharma firm has filed 12 ANDAs (abbreviated new drug applications) during the March quarter, taking the total filings in FY18 to 26.
The pharma firm has filed 12 ANDAs (abbreviated new drug applications) during the March quarter, taking the total filings in FY18 to 26.